News|Articles|July 18, 2024

Pharma Pulse 7/18/24: Improving Medication Reconciliation Accuracy, Synchron Says AI Will Be Instrumental for Devices & more

The latest news for pharma industry insiders.

Patient-centric Approaches in Designing and Creating Products

Kristy Birchard, product owner, patient engagement, YPrime discusses the importance of designing products based on the experience of patients.

Improving Medication Reconciliation Accuracy in a Primary Care Practice

Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.

Brain Startup Synchron Says AI Will Be Instrumental for Devices

Medical device maker has integrated OpenAI’s latest AI model into its technology.

RedBox Rx Launches Online Talk Therapy Services to Increase Access to Mental Health Care

RedBox Rx announced the launch of online talk therapy services to its platform. This service offering helps expand access to mental health care treatment across the country.

Abid Rahman on LinkedIn

AI has a role play in almost every aspect of the pharma industry. Here are my thoughts on AI's role in Drug launch, operations and pricing.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

Pharmaceutical Executive Daily
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.